CN105747211A - 一种婴幼儿营养液 - Google Patents
一种婴幼儿营养液 Download PDFInfo
- Publication number
- CN105747211A CN105747211A CN201610101020.7A CN201610101020A CN105747211A CN 105747211 A CN105747211 A CN 105747211A CN 201610101020 A CN201610101020 A CN 201610101020A CN 105747211 A CN105747211 A CN 105747211A
- Authority
- CN
- China
- Prior art keywords
- vitamin
- infant
- nutrient solution
- solution
- calcium
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 235000015097 nutrients Nutrition 0.000 title abstract description 16
- OVBPIULPVIDEAO-LBPRGKRZSA-N folic acid Chemical compound C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)N[C@@H](CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-LBPRGKRZSA-N 0.000 claims abstract description 12
- 239000011716 vitamin B2 Substances 0.000 claims abstract description 7
- OVBPIULPVIDEAO-UHFFFAOYSA-N N-Pteroyl-L-glutaminsaeure Natural products C=1N=C2NC(N)=NC(=O)C2=NC=1CNC1=CC=C(C(=O)NC(CCC(O)=O)C(O)=O)C=C1 OVBPIULPVIDEAO-UHFFFAOYSA-N 0.000 claims abstract description 6
- 229960000304 folic acid Drugs 0.000 claims abstract description 6
- 235000019152 folic acid Nutrition 0.000 claims abstract description 6
- 239000011724 folic acid Substances 0.000 claims abstract description 6
- 239000011726 vitamin B6 Substances 0.000 claims abstract description 5
- 239000011715 vitamin B12 Substances 0.000 claims abstract description 4
- 235000016709 nutrition Nutrition 0.000 claims description 27
- 230000035764 nutrition Effects 0.000 claims description 14
- 239000007788 liquid Substances 0.000 claims description 12
- 238000003756 stirring Methods 0.000 claims description 8
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 claims description 7
- 239000000284 extract Substances 0.000 claims description 7
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 7
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 claims description 6
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 claims description 6
- 229930006000 Sucrose Natural products 0.000 claims description 6
- 239000008213 purified water Substances 0.000 claims description 6
- OENHQHLEOONYIE-UKMVMLAPSA-N all-trans beta-carotene Natural products CC=1CCCC(C)(C)C=1/C=C/C(/C)=C/C=C/C(/C)=C/C=C/C=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C OENHQHLEOONYIE-UKMVMLAPSA-N 0.000 claims description 4
- 239000011648 beta-carotene Substances 0.000 claims description 4
- 235000013734 beta-carotene Nutrition 0.000 claims description 4
- TUPZEYHYWIEDIH-WAIFQNFQSA-N beta-carotene Natural products CC(=C/C=C/C=C(C)/C=C/C=C(C)/C=C/C1=C(C)CCCC1(C)C)C=CC=C(/C)C=CC2=CCCCC2(C)C TUPZEYHYWIEDIH-WAIFQNFQSA-N 0.000 claims description 4
- 229960002747 betacarotene Drugs 0.000 claims description 4
- ZUFQODAHGAHPFQ-UHFFFAOYSA-N pyridoxine hydrochloride Chemical compound Cl.CC1=NC=C(CO)C(CO)=C1O ZUFQODAHGAHPFQ-UHFFFAOYSA-N 0.000 claims description 4
- OENHQHLEOONYIE-JLTXGRSLSA-N β-Carotene Chemical compound CC=1CCCC(C)(C)C=1\C=C\C(\C)=C\C=C\C(\C)=C\C=C\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C OENHQHLEOONYIE-JLTXGRSLSA-N 0.000 claims description 4
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 claims description 3
- DKKCQDROTDCQOR-UHFFFAOYSA-L Ferrous lactate Chemical compound [Fe+2].CC(O)C([O-])=O.CC(O)C([O-])=O DKKCQDROTDCQOR-UHFFFAOYSA-L 0.000 claims description 3
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 claims description 3
- 229930003270 Vitamin B Natural products 0.000 claims description 3
- 229930003268 Vitamin C Natural products 0.000 claims description 3
- 229930003316 Vitamin D Natural products 0.000 claims description 3
- QYSXJUFSXHHAJI-XFEUOLMDSA-N Vitamin D3 Natural products C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C/C=C1\C[C@@H](O)CCC1=C QYSXJUFSXHHAJI-XFEUOLMDSA-N 0.000 claims description 3
- 229930003427 Vitamin E Natural products 0.000 claims description 3
- CANRESZKMUPMAE-UHFFFAOYSA-L Zinc lactate Chemical compound [Zn+2].CC(O)C([O-])=O.CC(O)C([O-])=O CANRESZKMUPMAE-UHFFFAOYSA-L 0.000 claims description 3
- FAPWYRCQGJNNSJ-UBKPKTQASA-L calcium D-pantothenic acid Chemical compound [Ca+2].OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O.OCC(C)(C)[C@@H](O)C(=O)NCCC([O-])=O FAPWYRCQGJNNSJ-UBKPKTQASA-L 0.000 claims description 3
- 239000004227 calcium gluconate Substances 0.000 claims description 3
- 235000013927 calcium gluconate Nutrition 0.000 claims description 3
- 229960004494 calcium gluconate Drugs 0.000 claims description 3
- MKJXYGKVIBWPFZ-UHFFFAOYSA-L calcium lactate Chemical compound [Ca+2].CC(O)C([O-])=O.CC(O)C([O-])=O MKJXYGKVIBWPFZ-UHFFFAOYSA-L 0.000 claims description 3
- 239000001527 calcium lactate Substances 0.000 claims description 3
- 235000011086 calcium lactate Nutrition 0.000 claims description 3
- 229960002401 calcium lactate Drugs 0.000 claims description 3
- 229960002079 calcium pantothenate Drugs 0.000 claims description 3
- NEEHYRZPVYRGPP-UHFFFAOYSA-L calcium;2,3,4,5,6-pentahydroxyhexanoate Chemical compound [Ca+2].OCC(O)C(O)C(O)C(O)C([O-])=O.OCC(O)C(O)C(O)C(O)C([O-])=O NEEHYRZPVYRGPP-UHFFFAOYSA-L 0.000 claims description 3
- 238000005352 clarification Methods 0.000 claims description 3
- FDJOLVPMNUYSCM-WZHZPDAFSA-L cobalt(3+);[(2r,3s,4r,5s)-5-(5,6-dimethylbenzimidazol-1-yl)-4-hydroxy-2-(hydroxymethyl)oxolan-3-yl] [(2r)-1-[3-[(1r,2r,3r,4z,7s,9z,12s,13s,14z,17s,18s,19r)-2,13,18-tris(2-amino-2-oxoethyl)-7,12,17-tris(3-amino-3-oxopropyl)-3,5,8,8,13,15,18,19-octamethyl-2 Chemical compound [Co+3].N#[C-].N([C@@H]([C@]1(C)[N-]\C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C(\C)/C1=N/C([C@H]([C@@]1(CC(N)=O)C)CCC(N)=O)=C\C1=N\C([C@H](C1(C)C)CCC(N)=O)=C/1C)[C@@H]2CC(N)=O)=C\1[C@]2(C)CCC(=O)NC[C@@H](C)OP([O-])(=O)O[C@H]1[C@@H](O)[C@@H](N2C3=CC(C)=C(C)C=C3N=C2)O[C@@H]1CO FDJOLVPMNUYSCM-WZHZPDAFSA-L 0.000 claims description 3
- 235000013925 ferrous lactate Nutrition 0.000 claims description 3
- 239000004225 ferrous lactate Substances 0.000 claims description 3
- 229940037907 ferrous lactate Drugs 0.000 claims description 3
- 239000012467 final product Substances 0.000 claims description 3
- 235000021433 fructose syrup Nutrition 0.000 claims description 3
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 claims description 3
- 239000004519 grease Substances 0.000 claims description 3
- 238000000034 method Methods 0.000 claims description 3
- 239000000843 powder Substances 0.000 claims description 3
- 239000005720 sucrose Substances 0.000 claims description 3
- 229960004793 sucrose Drugs 0.000 claims description 3
- -1 sucrose ester Chemical class 0.000 claims description 3
- 235000019156 vitamin B Nutrition 0.000 claims description 3
- 239000011720 vitamin B Substances 0.000 claims description 3
- 235000019154 vitamin C Nutrition 0.000 claims description 3
- 239000011718 vitamin C Substances 0.000 claims description 3
- 235000019166 vitamin D Nutrition 0.000 claims description 3
- 239000011710 vitamin D Substances 0.000 claims description 3
- 150000003710 vitamin D derivatives Chemical class 0.000 claims description 3
- 235000019165 vitamin E Nutrition 0.000 claims description 3
- 239000011709 vitamin E Substances 0.000 claims description 3
- 229940046009 vitamin E Drugs 0.000 claims description 3
- 229940046008 vitamin d Drugs 0.000 claims description 3
- 235000010493 xanthan gum Nutrition 0.000 claims description 3
- 239000000230 xanthan gum Substances 0.000 claims description 3
- 229920001285 xanthan gum Polymers 0.000 claims description 3
- 229940082509 xanthan gum Drugs 0.000 claims description 3
- 239000011576 zinc lactate Substances 0.000 claims description 3
- 235000000193 zinc lactate Nutrition 0.000 claims description 3
- 229940050168 zinc lactate Drugs 0.000 claims description 3
- 230000012010 growth Effects 0.000 abstract description 9
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 abstract description 6
- 230000000694 effects Effects 0.000 abstract description 6
- 229910052500 inorganic mineral Inorganic materials 0.000 abstract description 5
- 235000010755 mineral Nutrition 0.000 abstract description 5
- 239000011707 mineral Substances 0.000 abstract description 5
- 229940088594 vitamin Drugs 0.000 abstract description 5
- 229930003231 vitamin Natural products 0.000 abstract description 5
- 235000013343 vitamin Nutrition 0.000 abstract description 5
- 239000011782 vitamin Substances 0.000 abstract description 5
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 abstract description 4
- 230000015572 biosynthetic process Effects 0.000 abstract description 4
- 239000011575 calcium Substances 0.000 abstract description 4
- 229910052791 calcium Inorganic materials 0.000 abstract description 4
- 230000036039 immunity Effects 0.000 abstract description 4
- 239000000126 substance Substances 0.000 abstract description 4
- 239000011691 vitamin B1 Substances 0.000 abstract description 4
- 238000010521 absorption reaction Methods 0.000 abstract description 3
- 201000010099 disease Diseases 0.000 abstract description 3
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 abstract description 3
- 230000000968 intestinal effect Effects 0.000 abstract description 3
- 229910052742 iron Inorganic materials 0.000 abstract description 3
- 235000013406 prebiotics Nutrition 0.000 abstract description 3
- 230000001502 supplementing effect Effects 0.000 abstract description 3
- 235000010374 vitamin B1 Nutrition 0.000 abstract description 2
- 235000019164 vitamin B2 Nutrition 0.000 abstract description 2
- 235000019158 vitamin B6 Nutrition 0.000 abstract description 2
- 230000001737 promoting effect Effects 0.000 abstract 2
- 235000021388 linseed oil Nutrition 0.000 abstract 1
- 239000000944 linseed oil Substances 0.000 abstract 1
- 238000007254 oxidation reaction Methods 0.000 abstract 1
- 235000019163 vitamin B12 Nutrition 0.000 abstract 1
- 239000000243 solution Substances 0.000 description 18
- 239000002994 raw material Substances 0.000 description 7
- 230000018109 developmental process Effects 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- 239000000463 material Substances 0.000 description 5
- 238000002360 preparation method Methods 0.000 description 5
- DTOSIQBPPRVQHS-PDBXOOCHSA-N alpha-linolenic acid Chemical compound CC\C=C/C\C=C/C\C=C/CCCCCCCC(O)=O DTOSIQBPPRVQHS-PDBXOOCHSA-N 0.000 description 4
- 210000004556 brain Anatomy 0.000 description 4
- 150000003722 vitamin derivatives Chemical class 0.000 description 4
- 229960005069 calcium Drugs 0.000 description 3
- 239000007952 growth promoter Substances 0.000 description 3
- 230000036541 health Effects 0.000 description 3
- 230000001105 regulatory effect Effects 0.000 description 3
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 3
- 239000011573 trace mineral Substances 0.000 description 3
- 235000013619 trace mineral Nutrition 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 2
- 230000001476 alcoholic effect Effects 0.000 description 2
- 235000020661 alpha-linolenic acid Nutrition 0.000 description 2
- 208000007502 anemia Diseases 0.000 description 2
- 230000003064 anti-oxidating effect Effects 0.000 description 2
- 230000009286 beneficial effect Effects 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 230000024245 cell differentiation Effects 0.000 description 2
- 239000003814 drug Substances 0.000 description 2
- 229940088598 enzyme Drugs 0.000 description 2
- 230000004438 eyesight Effects 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 229960004488 linolenic acid Drugs 0.000 description 2
- 230000004060 metabolic process Effects 0.000 description 2
- 239000000047 product Substances 0.000 description 2
- 108090000623 proteins and genes Proteins 0.000 description 2
- 102000004169 proteins and genes Human genes 0.000 description 2
- 239000013589 supplement Substances 0.000 description 2
- 238000003786 synthesis reaction Methods 0.000 description 2
- 210000001519 tissue Anatomy 0.000 description 2
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- FPIPGXGPPPQFEQ-UHFFFAOYSA-N 13-cis retinol Natural products OCC=C(C)C=CC=C(C)C=CC1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-UHFFFAOYSA-N 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 241000894006 Bacteria Species 0.000 description 1
- 241000186016 Bifidobacterium bifidum Species 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- 206010012735 Diarrhoea Diseases 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 1
- 206010019280 Heart failures Diseases 0.000 description 1
- 206010024561 Lip pain Diseases 0.000 description 1
- 208000002720 Malnutrition Diseases 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 201000005505 Measles Diseases 0.000 description 1
- 206010061291 Mineral deficiency Diseases 0.000 description 1
- 208000012902 Nervous system disease Diseases 0.000 description 1
- 206010067482 No adverse event Diseases 0.000 description 1
- 208000008589 Obesity Diseases 0.000 description 1
- 206010031009 Oral pain Diseases 0.000 description 1
- 208000001132 Osteoporosis Diseases 0.000 description 1
- 201000002451 Overnutrition Diseases 0.000 description 1
- 206010035664 Pneumonia Diseases 0.000 description 1
- 206010044302 Tracheitis Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 241001464837 Viridiplantae Species 0.000 description 1
- FPIPGXGPPPQFEQ-BOOMUCAASA-N Vitamin A Natural products OC/C=C(/C)\C=C\C=C(\C)/C=C/C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-BOOMUCAASA-N 0.000 description 1
- 208000010011 Vitamin A Deficiency Diseases 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 229930003471 Vitamin B2 Natural products 0.000 description 1
- LXNHXLLTXMVWPM-UHFFFAOYSA-N Vitamin B6 Natural products CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 1
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 description 1
- 230000004913 activation Effects 0.000 description 1
- 230000003044 adaptive effect Effects 0.000 description 1
- FPIPGXGPPPQFEQ-OVSJKPMPSA-N all-trans-retinol Chemical compound OC\C=C(/C)\C=C\C=C(/C)\C=C\C1=C(C)CCCC1(C)C FPIPGXGPPPQFEQ-OVSJKPMPSA-N 0.000 description 1
- 102000004139 alpha-Amylases Human genes 0.000 description 1
- 108090000637 alpha-Amylases Proteins 0.000 description 1
- 229940024171 alpha-amylase Drugs 0.000 description 1
- 230000036506 anxiety Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 235000020980 bad eating habits Nutrition 0.000 description 1
- 235000004251 balanced diet Nutrition 0.000 description 1
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 1
- GUBGYTABKSRVRQ-QUYVBRFLSA-N beta-maltose Chemical compound OC[C@H]1O[C@H](O[C@H]2[C@H](O)[C@@H](O)[C@H](O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@@H]1O GUBGYTABKSRVRQ-QUYVBRFLSA-N 0.000 description 1
- 230000037396 body weight Effects 0.000 description 1
- 210000004958 brain cell Anatomy 0.000 description 1
- 210000005056 cell body Anatomy 0.000 description 1
- 230000011712 cell development Effects 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 238000006243 chemical reaction Methods 0.000 description 1
- 230000000295 complement effect Effects 0.000 description 1
- 230000007423 decrease Effects 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- CYQFCXCEBYINGO-IAGOWNOFSA-N delta1-THC Chemical compound C1=C(C)CC[C@H]2C(C)(C)OC3=CC(CCCCC)=CC(O)=C3[C@@H]21 CYQFCXCEBYINGO-IAGOWNOFSA-N 0.000 description 1
- 235000005911 diet Nutrition 0.000 description 1
- 230000037213 diet Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 230000004069 differentiation Effects 0.000 description 1
- 230000001079 digestive effect Effects 0.000 description 1
- 210000002249 digestive system Anatomy 0.000 description 1
- 238000004090 dissolution Methods 0.000 description 1
- 229940079593 drug Drugs 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 210000003743 erythrocyte Anatomy 0.000 description 1
- 235000004626 essential fatty acids Nutrition 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 230000004578 fetal growth Effects 0.000 description 1
- 239000000706 filtrate Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 230000007661 gastrointestinal function Effects 0.000 description 1
- 206010018388 glossodynia Diseases 0.000 description 1
- 239000008103 glucose Substances 0.000 description 1
- 125000005456 glyceride group Chemical group 0.000 description 1
- 230000036737 immune function Effects 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 238000001727 in vivo Methods 0.000 description 1
- 201000002364 leukopenia Diseases 0.000 description 1
- 231100001022 leukopenia Toxicity 0.000 description 1
- 230000037356 lipid metabolism Effects 0.000 description 1
- 230000007774 longterm Effects 0.000 description 1
- 230000001071 malnutrition Effects 0.000 description 1
- 235000000824 malnutrition Nutrition 0.000 description 1
- 238000004519 manufacturing process Methods 0.000 description 1
- 210000000214 mouth Anatomy 0.000 description 1
- 210000004877 mucosa Anatomy 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 230000001473 noxious effect Effects 0.000 description 1
- 235000021048 nutrient requirements Nutrition 0.000 description 1
- 208000015380 nutritional deficiency disease Diseases 0.000 description 1
- 235000008935 nutritious Nutrition 0.000 description 1
- 235000020824 obesity Nutrition 0.000 description 1
- 235000020660 omega-3 fatty acid Nutrition 0.000 description 1
- 229940012843 omega-3 fatty acid Drugs 0.000 description 1
- 235000020823 overnutrition Nutrition 0.000 description 1
- 150000003904 phospholipids Chemical class 0.000 description 1
- 230000035790 physiological processes and functions Effects 0.000 description 1
- 230000008092 positive effect Effects 0.000 description 1
- 230000002265 prevention Effects 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 108090000765 processed proteins & peptides Proteins 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- 210000002345 respiratory system Anatomy 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 230000001835 salubrious effect Effects 0.000 description 1
- 210000000952 spleen Anatomy 0.000 description 1
- 210000002784 stomach Anatomy 0.000 description 1
- 238000003860 storage Methods 0.000 description 1
- 230000009469 supplementation Effects 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- 230000003867 tiredness Effects 0.000 description 1
- 208000016255 tiredness Diseases 0.000 description 1
- 230000008359 toxicosis Effects 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
- 235000019155 vitamin A Nutrition 0.000 description 1
- 239000011719 vitamin A Substances 0.000 description 1
- 229940045997 vitamin a Drugs 0.000 description 1
- 229940082632 vitamin b12 and folic acid Drugs 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 239000011670 zinc gluconate Substances 0.000 description 1
- 235000011478 zinc gluconate Nutrition 0.000 description 1
- 229960000306 zinc gluconate Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Abstract
本发明公开了一种婴幼儿营养液，它由亚麻籽油、麦芽提取物、益生元、维生素和矿物质等多种营养物质组成。本发明所提供的营养液营养全面，配方科学，能很好地补充婴幼儿的营养。该营养液具有抗氧化作用，能够促进婴幼儿的生长发育特别是智力发育，提高婴幼儿机体对疾病的抵抗力和免疫力。同时，该营养液还能调节肠道内平衡，促进维生素B1、B2、B6、B12及叶酸的自然形成，以及微量元素铁、钙的吸收与利用。
Description
技术领域
本发明属于营养保健食品技术领域，具体涉及一种婴幼儿营养液。
背景技术
婴幼儿阶段是人一生中生长最快的阶段，如果营养不良不仅会造成婴幼儿体重减轻、身材矮小，而且影响其智力发展；而营养过剩也会导致肥胖等多种疾患。因此在该阶段适当、全面地补充各种营养是十分必要的。由于成人对婴幼儿的营养补充过于关注和焦虑，但又缺乏科学的知识，所以在营养方式上出现了许多误区，从而影响了婴幼儿的生长发育。
婴幼儿对营养素的需要量与成人存在很大差异，婴幼儿愈小相对体重而言的营养素需要量就愈高。同时由于婴幼儿体内营养素的储备量相对较小，适应能力也差，一旦不能及时合理地摄入某些营养素或者消化功能紊乱，短时间内就可明显影响婴幼儿的生长发育。因此，针对婴幼儿时期的膳食结构和生理特点，在强调均衡饮食、改变不良饮食习惯的同时，对各种营养素进行有针对性的科学合理的补充是十分必要的。
目前，市场上虽然有许多用于婴幼儿补充的维生素、矿物质类的药品和保健品，如维C片，补钙、补锌口服液等，这些药品和保健品虽可以补充婴幼儿体内维生素、矿物质缺乏症，但由于它们成分单一，也并没有针对婴幼儿生长发育所需各种营养素的实际情况，所以并不能满足婴幼儿阶段对多种维生素和矿物质的需求。因而难以达到理想的效果。
发明内容
本发明的目的是针对上述问题，提供一种适合于婴幼儿的营养液，其含有亚麻籽油、麦芽提取物、益生元及维生素和矿物质等多种营养元素，有助于促进婴幼儿智力发育和提高免疫力，更好地补充婴幼儿在生长发育阶段所需的各种营养物质。
本发明的另一个目的是提供了上述营养液的制备方法。
本发明所提供的婴幼儿营养液，按每100mL计，所述营养液中含有以下成分：
优选地，所述婴幼儿营养液，按每100mL计，所述营养液中含有以下成分：
采用该配比的营养液营养元素搭配最合理，最有利于婴幼儿的成长发育，同时营养液的性质最稳定，口感最佳。
本发明所提供的制备方法是：按配比称取维生素E、亚麻籽油、麦芽提取物、果葡糖浆、黄原胶、葡萄糖酸钙、乳酸钙、乳酸亚铁、乳酸锌、蔗糖酯，加入少量的70-80℃纯化水，搅拌至完全溶解，均质脱气至溶液澄清且上层无油状物；再按配比称取维生素D、维生素B1、叶酸、维生素C、维生素B2、泛酸钙、维生素B6、维生素B12、β-胡萝卜素、烟酰胺、低聚果糖、白砂糖、甜橙粉，待上述溶液降至50℃后加入，搅拌至完全溶解，再加入1％CMC溶液，加纯化水至100mL，继续搅拌，均质脱气后即得。
本发明的有益效果是：
本发明所提供的营养液营养全面，配方科学，含有婴幼儿生长发育期间所需的各种维生素、矿物质以及益生元，能很好地补充营养。该营养液具有抗氧化作用，能够促进婴幼儿的生长发育特别是智力发育，提高婴幼儿机体对疾病的抵抗力和免疫力。同时，该营养液还能调节肠道内平衡，促进维生素B1、B2、B6、B12及叶酸的自然形成，以及微量元素铁、钙的吸收与利用。各成分相互配伍，起到互相促进，互相补充、相辅相成的作用，从而更好地发挥功效，长期服用无不良反应或副作用。
本发明具有麦芽香和水果香，口味好，婴幼儿容易接受；溶液澄清、质量稳定性好。
具体实施方式
实施例1
婴幼儿营养液100mL，是由以下原料组成的，各原料的重量配比为：
所述麦芽提取物，它是按以下方法制备的：取麦芽，除杂质后粉碎，用α-淀粉酶进行酶解，加酶量为30U/g，酶解过程保持在40-50℃，水添加量为30％(按麦芽的重量)，保持PH值为5左右，酶解时间为25-30h，酶解完成后，加入麦芽重量10倍的乙醇溶液，乙醇溶液的重量浓度为60％，提取8h，过滤，滤液进行真空浓缩、干燥粉碎后即得。
下面介绍一下主要成分：
亚麻籽油：含有50％以上的欧米伽3脂肪酸母体物质α-亚麻酸，其脂肪酸组成中的欧米伽3、6、9是最合理的配比，α-亚麻酸是维系人类脑进化的生命核心物质，以甘油酯的形式存在于深绿色植物中，是构成人体组织细胞的重要成分，它维系人体进化，保持身体健康的人体必需脂肪酸。在体内参与磷脂的合成、代谢、转化为人体必需的生命活性因子DHA和EPA；而DHA是大脑形成和智商开发的必需物质，对视觉、大脑活动、脂肪代谢、胎儿生长及免疫功能都有极大影响。
麦芽提取物：富含麦芽糖、果糖、葡萄糖、小分子蛋白肽、多种维生素和微量元素等，具有抗氧化功能，可改善肠胃功能，健胃健脾，消除疲劳，振奋精神，提高婴幼儿免疫力。同时，因其具有麦芽香味，可改善食品口味。
低聚果糖：是肠内双歧杆菌的活化增殖因子，可减少和抑制肠内腐败物质的产生，抑制有害细菌的生长，调节肠道内平衡；能促进微量元素铁、钙的吸收与利用，以防止骨质疏松症。
β-胡萝卜素：可作为获得维生素A的途径，能帮助维持人眼睛的正常视力，维持皮肤的正常生长分化，维持呼吸系统和消化系统的正常抵抗力，还影响着婴幼儿的生长发育状况。轻度的维生素A缺乏就会引起抵抗力下降，婴幼儿容易患上麻疹、肺炎、气管炎、腹泻等疾病，严重的甚至会失明。
维生素B1：可以调节神经、肌肉系统的兴奋和传导，是维持大脑正常生理功能的基础原料。乳母严重缺乏维生素B1，可使婴儿出现瘫软无力等神经系统疾病，重者可发生心力衰竭。
维生素B2：能帮助人体获得能量，也能维持身体组织的正常更新。如果缺乏维生素B2，可能发生嘴角疼、舌头疼、嘴唇疼、眼白发红、怕光流泪等症状，还会影响面部皮肤的清爽。
叶酸：是与体内各种反应有关的成分，能与约20种酶共同促成DNA的合成及细胞分化，所以对细胞分化正盛的婴幼儿的发育有着积极的作用；是制造红血球不可缺少的物质，有助于预防婴幼儿贫血；能防治食物中毒和各种肠道寄生虫；能预防婴幼儿口腔黏膜溃疡；有助于蛋白质的基础代谢，对于身体细胞的分裂也是不可或缺的；对婴幼儿的神经细胞与脑细胞发育有促进作用，维持脑的正常运作，并能提高婴幼儿的智力。如果缺乏叶酸可导致红血球的异常，未成熟细胞的增加、贫血以及白血球减少。
所述婴幼儿营养液的制备工艺是：
按上述配方量称取维生素E、亚麻籽油、麦芽提取物、果葡糖浆、黄原胶、葡萄糖酸钙、乳酸钙、乳酸亚铁、乳酸锌、蔗糖酯，加入少量的70-80℃纯化水，加热搅拌至原料完全溶解，均质脱气至溶液澄清且上层无油状物；按配方量称取维生素D、维生素B1、叶酸、维生素C、维生素B2、泛酸钙、维生素B6、维生素B12、β-胡萝卜素、烟酰胺、低聚果糖、白砂糖、甜橙粉，待上述溶液降至50℃后加入，搅拌使原料溶解，再加入配方量的1％(重量浓度)CMC水溶液，加纯化水至100mL,继续搅拌均质脱气使混合均匀，即得婴幼儿营养液。
实施例2
婴幼儿营养液，它是由以下原料组成的，各原料的重量配比为：
制备方法与实施例1相同。
实施例3
婴幼儿营养液100mL，是由以下原料组成的，各原料的重量配比为：
制备方法与实施例1相同。
Claims (3)
1.一种婴幼儿营养液，其特征在于：按每100mL计，所述营养液中含有以下成分：
2.如权利要求1所述的婴幼儿营养液，其特征在于：按每100mL计，所述营养液中含有以下成分：
3.一种制备权利要求1或2所述婴幼儿营养液的方法，其特征在于：按配比称取维生素E、亚麻籽油、麦芽提取物、果葡糖浆、黄原胶、葡萄糖酸钙、乳酸钙、乳酸亚铁、乳酸锌、蔗糖酯，加入少量的70-80℃纯化水，搅拌至完全溶解，均质脱气至溶液澄清且上层无油状物；再按配比称取维生素D、维生素B1、叶酸、维生素C、维生素B2、泛酸钙、维生素B6、维生素B12、β-胡萝卜素、烟酰胺、低聚果糖、白砂糖、甜橙粉，待上述溶液降至50℃后加入，搅拌至完全溶解，再加入1％CMC溶液，加纯化水至100mL，继续搅拌，均质脱气后即得。
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610101020.7A CN105747211A (zh) | 2016-02-24 | 2016-02-24 | 一种婴幼儿营养液 |
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN201610101020.7A CN105747211A (zh) | 2016-02-24 | 2016-02-24 | 一种婴幼儿营养液 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| CN105747211A true CN105747211A (zh) | 2016-07-13 |
Family
ID=56331122
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| CN201610101020.7A Pending CN105747211A (zh) | 2016-02-24 | 2016-02-24 | 一种婴幼儿营养液 |
Country Status (1)
| Country | Link |
|---|---|
| CN (1) | CN105747211A (zh) |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108433097A (zh) * | 2018-03-02 | 2018-08-24 | 汕头美亨利乐生物科技有限公司 | 具有改善肠道吸收功能的辅食营养补充品及其制备方法 |
| CN111374307A (zh) * | 2020-03-30 | 2020-07-07 | 江西师范大学 | 抗消化性鱼皮明胶复合凝胶补锌营养包及其制备方法和应用 |
| CN112890182A (zh) * | 2021-03-09 | 2021-06-04 | 杭州贝聪美健康科技有限公司 | 一种适用于婴幼儿的营养包 |
Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101278688A (zh) * | 2008-05-22 | 2008-10-08 | 澳大利亚迪唯恩乳业有限公司 | 婴幼儿营养免疫配方奶粉及其生产方法 |
| CN101427783A (zh) * | 2008-07-09 | 2009-05-13 | 内蒙古蒙牛乳业（集团）股份有限公司 | 一种添加植物脂肪粉的孕产妇型液态奶及其制备方法 |
| CN104839727A (zh) * | 2015-06-05 | 2015-08-19 | 南阳市汇博生物技术有限公司 | 一种医用全营养配方乳剂型食品及其制备方法 |
-
2016
- 2016-02-24 CN CN201610101020.7A patent/CN105747211A/zh active Pending
Patent Citations (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN101278688A (zh) * | 2008-05-22 | 2008-10-08 | 澳大利亚迪唯恩乳业有限公司 | 婴幼儿营养免疫配方奶粉及其生产方法 |
| CN101427783A (zh) * | 2008-07-09 | 2009-05-13 | 内蒙古蒙牛乳业（集团）股份有限公司 | 一种添加植物脂肪粉的孕产妇型液态奶及其制备方法 |
| CN104839727A (zh) * | 2015-06-05 | 2015-08-19 | 南阳市汇博生物技术有限公司 | 一种医用全营养配方乳剂型食品及其制备方法 |
Non-Patent Citations (2)
| Title |
|---|
| （美）威廉•西尔斯著，邵艳美译: "《西尔斯亲密育儿百科》", 30 June 2015, 南海出版公司 * |
| 王福源主编: "《现代食品发酵技术》", 31 July 2004, 中国轻工业出版社 * |
Cited By (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN108433097A (zh) * | 2018-03-02 | 2018-08-24 | 汕头美亨利乐生物科技有限公司 | 具有改善肠道吸收功能的辅食营养补充品及其制备方法 |
| CN111374307A (zh) * | 2020-03-30 | 2020-07-07 | 江西师范大学 | 抗消化性鱼皮明胶复合凝胶补锌营养包及其制备方法和应用 |
| CN112890182A (zh) * | 2021-03-09 | 2021-06-04 | 杭州贝聪美健康科技有限公司 | 一种适用于婴幼儿的营养包 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ES2269514T3 (es) | Compuesto nutritivo para tratar afecciones inmunologicas. | |
| CN104287049A (zh) | 一种体重管理的代餐蛋白质粉固体饮料 | |
| CN101268835B (zh) | 一种儿童型营养高钙冲剂及其生产制作工艺 | |
| CN102429307A (zh) | 一种低热量全营养饮品及其制备方法 | |
| CN106259955A (zh) | 一种婴幼儿童超微钙铁锌多维素营养粉及其制备方法 | |
| CN106578571A (zh) | 改善宠物肠道功能的营养组合物、营养制剂及其制备方法和应用 | |
| CN106605709B (zh) | 一种适合3-6岁儿童的液态奶及其制备方法 | |
| CN101292752A (zh) | 一种鹰嘴豆豆奶营养饮料及其制备方法 | |
| CN103371318B (zh) | 一种膳食营养补充食品 | |
| CN111802476A (zh) | 一种提高儿童睡眠质量的奶粉及其制备方法 | |
| CN112189711A (zh) | 一种辅助降低三高的中老年奶粉 | |
| CN109329848A (zh) | 一种含低聚木糖的芝麻丸配方及制备方法 | |
| CN101720956B (zh) | 香蕉饮料及其制备方法 | |
| CN105747211A (zh) | 一种婴幼儿营养液 | |
| CN105432792A (zh) | 一种学龄前儿童基础营养奶粉、营养粉套装及制备方法 | |
| CN117859892A (zh) | 一种基于动植物双蛋白的凝胶状全营养特医食品配方及其制备方法 | |
| CN104921123A (zh) | 一种促进幼儿眼脑发育的组合物及其制备方法 | |
| RU2525338C2 (ru) | Инстантный функциональный пищевой продукт | |
| CN103609748A (zh) | 一种降血糖孕妇奶粉及其制备方法 | |
| CN113678898A (zh) | 一种有助于儿童发育成长的奶粉及其制备方法 | |
| CN107136376A (zh) | 一种大豆蛋白固体饮料 | |
| US20210037854A1 (en) | Eggs rich in nutrients of alpha-linolenic acid and dha, breeding method of laying hens, and feed additive | |
| CN113678897A (zh) | 一种促进孕产妇营养吸收的配方奶粉及其制备方法 | |
| CN105596342A (zh) | 一种儿童补铁与维生素的组合物及其制备方法和应用 | |
| CN115886171B (zh) | 一种复合型固体饮料及其制备方法 |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| C06 | Publication | ||
| PB01 | Publication | ||
| C10 | Entry into substantive examination | ||
| SE01 | Entry into force of request for substantive examination | ||
| RJ01 | Rejection of invention patent application after publication | ||
| RJ01 | Rejection of invention patent application after publication |
Application publication date: 20160713 |